Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
abrdn Diversifiedome and Growth's revenue for the
six
months ended in Sep. 2025 was £-48.69 Mil.
Its revenue for the trailing twelve months (TTM) ended in Sep. 2025 was £-39.32 Mil.
abrdn Diversifiedome and Growth's Revenue per Share for the
six
months ended in Sep. 2025 was £-0.16.
Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2025 was £-0.13.
During the past 13 years, abrdn Diversifiedome and Growth's highest 3-Year average Revenue per Share Growth Rate was 49.30% per year. The lowest was -65.20% per year. And the median was -0.70% per year.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
abrdn Diversifiedome and Growth Revenue Related Terms
abrdn Diversifiedome and Growth Revenue Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Asset Management subindustry, abrdn Diversifiedome and Growth's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
abrdn Diversifiedome and Growth Revenue vs Asset Management Industry
For the Asset Management industry and Financial Services sector, abrdn Diversifiedome and Growth's Revenue distribution charts can be found below:
* The bar in red indicates where abrdn Diversifiedome and Growth's Revenue falls into.
abrdn Diversifiedome and Growth Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Sep. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-39.32 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
abrdn Diversifiedome and Growth (LSE:ADIG) has a Revenue of £-39.32 Mil as of Sep. 2025. Revenue is the total amount a company generates as sales through its operations. View historical data on abrdn Diversifiedome and Growth and its competitors.
Is abrdn Diversifiedome and Growth's Revenue too high?
abrdn Diversifiedome and Growth's current Revenue is £-39.32 Mil. Overall, abrdn Diversifiedome and Growth has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does abrdn Diversifiedome and Growth's Revenue compare to BLK and BX?
abrdn Diversifiedome and Growth's Revenue of £-39.32 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for an Asset Management company?
A good Revenue depends on the Asset Management industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on abrdn Diversifiedome and Growth and its competitors. abrdn Diversifiedome and Growth's current Revenue is £-39.32 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is abrdn Diversifiedome and Growth stock overvalued right now?
abrdn Diversifiedome and Growth (LSE:ADIG) has a current Revenue of £-39.32 Mil. The stock's GF Value™ is £0.58, compared to a current price of £0.12 — trading 78.8% below its estimated fair value. The current Revenue is £-39.32 Mil. abrdn Diversifiedome and Growth's overall GF Score™ is 20/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For abrdn Diversifiedome and Growth (LSE:ADIG), the current Revenue is £-39.32 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is abrdn Diversifiedome and Growth (LSE:ADIG) Overvalued in 2026?
Based on GuruFocus' analysis, abrdn Diversifiedome and Growth stock appears to be undervalued.
The current stock price of £0.12 is trading 78.8% below its estimated GF Value™ of £0.58.
Key valuation signals for LSE:ADIG:
Revenue: £-39.32 Mil
GF Value™: £0.58 vs. price of £0.12 (78.8% below fair value)
No single metric tells the full story. See the LSE:ADIG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
abrdn Diversified Income and Growth PLC is an investment trust. It invests globally using a flexible multi-asset approach via quoted and unquoted investments. The company holds a diversified portfolio of financial instruments such as UK Equity Portfolio, Overseas Equity Income Sleeve, Fixed Income, Listed Alternatives, Cash and Cash Equivalents. The company has not restricted the exposure of investments for any geographical regions or sectors and will achieve an appropriate spread of risk by investing in a diversified portfolio of securities and other assets.
20GF Score
Get the complete analysis for LSE:ADIG
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:ADIG has been successfully added to your 
